These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24719065)

  • 1. Clinical evaluation and quantitative analysis of axillary hyperhidrosis treated with a unique targeted laser energy delivery method with 1-year follow up.
    Caplin D; Austin J
    J Drugs Dermatol; 2014 Apr; 13(4):449-56. PubMed ID: 24719065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of focal axillary hyperhidrosis using a long-pulsed Nd:YAG 1064 nm laser at hair reduction settings.
    Letada PR; Landers JT; Uebelhoer NS; Shumaker PR
    J Drugs Dermatol; 2012 Jan; 11(1):59-63. PubMed ID: 22206078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subdermal Nd-YAG laser for axillary hyperhidrosis.
    Goldman A; Wollina U
    Dermatol Surg; 2008 Jun; 34(6):756-62. PubMed ID: 18318722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of laser therapy on axillary hyperhidrosis after one year follow-up: a randomized blinded controlled trial.
    Leclère FM; Moreno-Moraga J; Alcolea JM; Vogt PM; Royo J; Cornejo P; Casoli V; Mordon S; Trelles MA
    Lasers Surg Med; 2015 Feb; 47(2):173-9. PubMed ID: 25663083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of refractory axillary hyperhidrosis with a 1320-nm Nd:YAG laser.
    Kotlus BS
    J Cosmet Laser Ther; 2011 Aug; 13(4):193-5. PubMed ID: 21692641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally invasive approaches to axillary osmidrosis treatment: A comparison between superficial liposuction with automatic shaver curettage, subcutaneous laser treatment, and microwave-based therapy with a modified technique.
    Yang HH; Miao Y; Chen YT; Hu ZQ
    J Cosmet Dermatol; 2019 Apr; 18(2):594-601. PubMed ID: 30203579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.
    Lowe NJ; Glaser DA; Eadie N; Daggett S; Kowalski JW; Lai PY;
    J Am Acad Dermatol; 2007 Apr; 56(4):604-11. PubMed ID: 17306417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diode laser hair removal does not interfere with botulinum toxin A treatment against axillary hyperhidrosis.
    Paul A; Kranz G; Schindl A; Kranz GS; Auff E; Sycha T
    Lasers Surg Med; 2010 Mar; 42(3):211-4. PubMed ID: 20333738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of fractional microneedle radiofrequency device in the treatment of primary axillary hyperhidrosis: a pilot study.
    Kim M; Shin JY; Lee J; Kim JY; Oh SH
    Dermatology; 2013; 227(3):243-9. PubMed ID: 24107595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multicenter Study for Cellulite Treatment Using a 1440-nm Nd:YAG Wavelength Laser with Side-Firing Fiber.
    DiBernardo BE; Sasaki GH; Katz BE; Hunstad JP; Petti C; Burns AJ
    Aesthet Surg J; 2016 Mar; 36(3):335-43. PubMed ID: 26879299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, blinded clinical evaluation of a novel microwave device for treating axillary hyperhidrosis: the dermatologic reduction in underarm perspiration study.
    Glaser DA; Coleman WP; Fan LK; Kaminer MS; Kilmer SL; Nossa R; Smith SR; O'Shaughnessy KF
    Dermatol Surg; 2012 Feb; 38(2):185-91. PubMed ID: 22289389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of methantheline bromide (Vagantin(®) ) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial.
    Müller C; Berensmeier A; Hamm H; Dirschka T; Reich K; Fischer T; Rzany B
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1278-84. PubMed ID: 23004926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attempted treatment of primary axillary hyperhidrosis with one session of either Neodymium YAG laser or Intense Pulsed Light: A within patient randomized trial of treated versus untreated contralateral axilla.
    Taudorf EH; Henning M; Olsen J; Thorlacius L; Christensen R; Jemec G
    Lasers Surg Med; 2023 Oct; 55(8):748-757. PubMed ID: 37313834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
    Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
    Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Subdermal Nd-YAG laser for axillary hyperhidrosis.
    Swinehart JM
    Dermatol Surg; 2009 Jun; 35(6):1018. PubMed ID: 19397648
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
    Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durability of botulinum toxin treatment for axillary hyperhidrosis.
    Moffat CE; Hayes WG; Nyamekye IK
    Eur J Vasc Endovasc Surg; 2009 Aug; 38(2):188-91. PubMed ID: 19395290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
    Heckmann M; Plewig G;
    Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single treatment of grades II and III cellulite using a minimally invasive 1,440-nm pulsed Nd:YAG laser and side-firing fiber: an institutional review board-approved study with a 24-month follow-up period.
    Sasaki GH
    Aesthetic Plast Surg; 2013 Dec; 37(6):1073-89. PubMed ID: 24114294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.